Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Clinical trial NCT00911534 · COMPLETED
Trial details
- NCT number
- NCT00911534
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-07-01
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.